The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation
Open accessAbstract
Background: The Epstein-Barr virus (EBV)-encoded EBNA1 protein is expressed in all EBV-associated tumours, including undifferentiated nasopharyngeal carcinoma (NPC), where it is indispensable for viral replication, genome maintenance and viral gene expression. EBNA1's transcription factor-like functions also extend to influencing the expression of cellular genes involved in pathways commonly dysregulated during oncogenesis, including elevation of AP-1 activity in NPC cell lines resulting in enhancement of angiogenesis in vitro. In this study we sought to extend these observations by examining the role of EBNA1 upon another pathway commonly deregulated during carcinogenesis; namely NF-κB. Results: In this report we demonstrate that EBNA1 inhibits the canonical NF-κB pathway in carcinoma lines by inhibiting the phosphorylation of IKKα/β. In agreement with this observation we find a reduction in the phosphorylation of IκBα and reduced phosphorylation and nuclear translocation of p65, resulting in a reduction in the amount of p65 in nuclear NF-κB complexes. Similar effects were also found in carcinoma lines infected with recombinant EBV and in the EBV-positive NPC-derived cell line C666-1. Inhibition of NF-κB was dependent upon regions of EBNA1 essential for gene transactivation whilst the interaction with the deubiquitinating enzyme, USP7, was entirely dispensable. Furthermore, in agreement with EBNA1 inhibiting p65 NF-κB we demonstrate that p65 was exclusively cytoplasmic in 11 out of 11 NPC tumours studied. Conclusions: Inhibition of p65 NF-κB in murine and human epidermis results in tissue hyperplasia and the development of squamous cell carcinoma. In line with this, p65 knockout fibroblasts have a transformed phenotype. Inhibition of p65 NF-κB by EBNA1 may therefore contribute to the development of NPC by inducing tissue hyperplasia. Furthermore, inhibition of NF-κB is employed by viruses as an immune evasion strategy which is also closely linked to oncogenesis during persistent viral infection. Our findings therefore further implicate EBNA1 in playing an important role in the pathogenesis of NPC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Epstein-Barr virus and its replication
Kieff, E. D. (1996) · Medical Entomology and Zoology · Cited by 1,627
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
Vermeulen, L. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg139 · Cited by 760
Hostile takeovers: viral appropriation of the NF-kB pathway
Hiscott, J., Kwon, H., & Génin, P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11918 · Cited by 613
Epstein–Barr virus in the pathogenesis of NPC
Raab-Traub, N. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x0200086x · Cited by 562
Epstein–Barr virus and oncogenesis: from latent genes to tumours
Young, L. S., & Murray, P. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206556 · Cited by 556
Self-citationNF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
Seitz, C. S., Lin, Q., Deng, H., & Khavari, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2307 · Cited by 436
NEW EMBO MEMBER'S REVIEW: NF-kappaB and virus infection: who controls whom
Santoro, M. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg267 · Cited by 396
Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
NF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 298
Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas
Busson, P., Ganem, G., Flores, P., Mugneret, F., Clausse, B., Caillou, B., Braham, K., Wakasugi, H., Lipinski, M., & Tursz, T. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420422 · Cited by 221
Renne, R., Barry, C., Dittmer, D., Compitello, N., Brown, P. O., & Ganem, D. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.458-468.2001 · Cited by 216
Baumforth, K. R. N., Birgersdotter, A., Reynolds, G. M., Wei, W., Kapatai, G., Flavell, J. R., Kalk, E., Piper, K., Lee, S., Machado, L., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070845 · Cited by 200
Self-citationHussain, S. A., Ganesan, R., Reynolds, G., Gross, L., Stevens, A., Pastorek, J., Murray, P. G., Perunovic, B., Anwar, M. S., Billingham, L., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603530 · Cited by 194
Cai, Q.-L., Knight, J. S., Verma, S. C., Zald, P., & Robertson, E. S. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020116 · Cited by 193
Mapping EBNA-1 Domains Involved in Binding to Metaphase Chromosomes
Marechal, V., Dehee, A., Chikhi-Brachet, R., Piolot, T., Coppey-Moisan, M., & Nicolas, J.-C. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4385-4392.1999 · Cited by 186
Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg, N. J., Rajadurai, P., & Raab‐Traub, N. (2003) · PubMed · Cited by 179
Inhibition of IκB Kinase by Vaccinia Virus Virulence Factor B14
Chen, R. A.-J., Ryzhakov, G., Cooray, S., Randow, F., & Smith, G. L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040022 · Cited by 155
Wood, V. H. J., O’Neil, J. D., Wei, W., Stewart, S. E., Dawson, W. O., & Young, L. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210496 · Cited by 144
Self-citationClassical and Alternative NF-.KAPPA.B Activation Pathways and Their Roles in Lymphoid Malignancies
Nishikori, M. (2005) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.45.15 · Cited by 143
Ruf, I. K., Rhyne, P., Yang, C., Cleveland, J. L., & Sample, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10223-10228.2000 · Cited by 138
O’Neil, J. D., Owen, T. J., Wood, V. H. J., Date, K. L., Valentine, R., Chukwuma, M. B., Arrand, J. R., Dawson, W. O., & Young, L. S. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/003392-0 · Cited by 137
Self-citationThe Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated
Sample, J. T., Henson, E. B., & Sample, C. E. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4654-4661.1992 · Cited by 131
Wu, H., Kapoor, P., & Frappier, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2480-2490.2002 · Cited by 125
Nuclear factor kappaB subunits induce epithelial cell growth arrest.
Seitz, C. S., Deng, H., Hinata, K., Lin, Q., & Khavari, P. A. (2000) · PubMed · Cited by 121
Huang, Y., Sheen, T., Chen, C. L., Lu, J., Chang, Y., Chen, J. Y., & Tsai, C.-H. A. (1999) · PubMed · Cited by 116
Stewart, S. E., Dawson, W. O., Takada, K., Curnow, J., Moody, C. A., Sixbey, J. W., & Young, L. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402135101 · Cited by 107
Self-citationArenzana‐Seisdedos, F., Fernandez, B., Dominguez, I. M., Jacqué, J. M., Thomas, D., Díaz-Meco, M. T., Moscat, J., & Virelizier, J. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6596-6604.1993 · Cited by 100
Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2
Srinivas, S., & Sixbey, J. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.8155-8158.1995 · Cited by 87
Ma, N., Kawanishi, M., Hiraku, Y., Murata, M., Huang, G., Huang, Y.-J., Luo, D., Wei-guang, M., Fukui, Y., & Kawanishi, S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23415 · Cited by 86
Rodrigues, L., Filipe, J. C.-R., Seldon, M. P., Fonseca, L., Anrather, J., Soares, M. P., & Simas, J. P. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.74 · Cited by 62
C/EBPβ Blocks p65 Phosphorylation and Thereby NF-κB-Mediated Transcription in TNF-Tolerant Cells
Zwergal, A., Quirling, M., Saugel, B., Huth, K. C., Sydlik, C., Poli, V., Neumeier, D., Ziegler‐Heitbrock, H. W. L., & Brand, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.665 · Cited by 61
Gapuzan, M.-E. R., Yufit, P. V., & Gilmore, T. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205333 · Cited by 53
Epstein-Barr Virus Nuclear Antigen 1 Does Not Cause Lymphoma in C57BL/6J Mice
Kang, M.-S., Soni, V., Bronson, R. T., & Kieff, E. D. (2008) · Journal of Virology · doi:10.1128/jvi.02596-07 · Cited by 50
HAUSP/USP7 as an Epstein–Barr virus target
Holowaty, M. N., & Frappier, L. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320731 · Cited by 48
Amir-Zilberstein, L., & Dikstein, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706767200 · Cited by 25
Cited by
Genetic compensation: A phenomenon in search of mechanisms
El-Brolosy, M. A., & Stainier, D. Y. R. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006780 · Cited by 829
Novel therapies emerging in oncology to target the TGF‐β pathway
Kim, B.-G., Malek, E., Choi, S. H., Ignatz-Hoover, J. J., & Driscoll, J. J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01053-x · Cited by 453
Modulation of NF-κB signalling by microbial pathogens
Rahman, M. M., & McFadden, G. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2539 · Cited by 400
circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family
Chen, L., Zhang, S., Wu, J., Cui, J., Zhong, L., Zeng, L., & Ge, S. (2017) · Oncogene · doi:10.1038/onc.2017.89 · Cited by 392
RetractedEpstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 361
Metadata
- Authors
- Valentine, R., Dawson, C. W., Hu, C., Shah, K. M., Owen, T. J., Date, K. L., Maia, S. P., Shao, J., Arrand, J. R., Young, L. S., & O'Neil, J. D.
- Venue
- Molecular Cancer
- Published
- 2010-01-05
- Volume
- 9
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W2111188487
- Cited by
- 353
- References
- 38
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.